Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

Trial Profile

Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Eltrombopag (Primary)
  • Indications Aplastic anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 27 May 2016 Status changed from recruiting to active, no longer recruiting.
    • 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association (n = 9).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top